Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 2, 2014
May 15, 2020
c027252e-0f07-4b88-baa1-313551e210ce
Related Documents
Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities: Guidance for Industry
Guidance DocumentJanuary 13, 2017Center for Drug Evaluation and Research
Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Guidance DocumentJanuary 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.